VytronUS Ablation System
Sponsors
VytronUS, Inc.
Conditions
Cardiac arrhythmia
recurrent paroxysmal atrial fibrillationParoxysmal Atrial Fibrillation
Unknown Phase
A Study of the Safety and Efficacy of the VytronUS Low-Intensity Collimated Ultrasound Ablation System
CompletedNCT01900678
Start: 2013-06-30End: 2015-01-31Updated: 2015-06-29
Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation
NCT03513029
Start: 2018-01-20End: 2019-12-31Target: 100Updated: 2018-05-01
Clinical Investigation of the VytronUS Ablation System for Treatment
of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation
Active, not recruitingNL-OMON46588
Start: 2018-09-24Target: 20Updated: 2024-02-28
Clinical Investigation of the VytronUS Ablation System for Treatment of Paroxysmal Atrial Fibrillation
CompletedNCT03639597
Start: 2016-01-18End: 2018-12-31Updated: 2019-04-24